checkAd

     185  0 Kommentare Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024 - Seite 2

    Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group. January 2024 Ascendis Pharma A/S.

    Investor Contacts:   Media Contact:
    Tim Lee   Melinda Baker
    Ascendis Pharma   Ascendis Pharma
    +1 (650) 374-6343   +1 (650) 709-8875
    tle@ascendispharma.com   media@ascendispharma.com
    ir@ascendispharma.com    
         
    Patti Bank    
    ICR Westwicke    
    +1 (415) 513-1284    
    patti.bank@westwicke.com    

    Lesen Sie auch

    Seite 2 von 2



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024 - Seite 2 COPENHAGEN, Denmark, Jan. 31, 2024 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report full year 2023 financial results and provide a business update on Wednesday, February 7, 2024, after the close of the U.S. …